Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OpenIMC: an open-source platform for analyzing single-cell and spatial proteomics by imaging mass cytometry.

BMC bioinformatics·2026
Same author

A Novel Patient-Derived Xenograft Model of Inflammatory Breast Cancer.

Research square·2026
Same author

OpenIMC: an open-source platform for analyzing single-cell and spatial proteomics by imaging mass cytometry.

Research square·2026
Same author

Comprehensive Molecular Characterization of High-Grade Endometrial Cancer in an Ancestrally Diverse Cohort.

bioRxiv : the preprint server for biology·2026
Same author

Intravital calcium imaging of meningeal macrophages reveals niche-specific dynamics and aberrant responses to brain hyperexcitability.

eLife·2026
Same author

Integrative Genomic, Transcriptomic, and Microbiome Profiles of Colon Cancer by Ancestry Provide Insights into Molecular Distinctions.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Jun 18, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Inferring tumor progression from genomic heterogeneity.

Nicholas Navin1, Alexander Krasnitz, Linda Rodgers

  • 1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA.

Genome Research
|November 12, 2009
PubMed
Summary
This summary is machine-generated.

Heterogeneous breast tumors reveal cancer progression pathways. Sector-Ploidy-Profiling (SPP) analyzes clonal subpopulations, showing polygenomic tumors arise from a few key clones, not gradual changes.

More Related Videos

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Related Experiment Videos

Last Updated: Jun 18, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Area of Science:

  • Oncology
  • Genomics
  • Cancer Biology

Background:

  • Inferring human cancer progression is challenging due to limited multi-stage sampling.
  • Heterogeneous breast tumors offer insights into tumor evolution by preserving early and intermediate subpopulations.
  • Phylogenetic relationships within tumors provide a roadmap for understanding clonal evolution.

Purpose of the Study:

  • To develop and apply a novel method for analyzing the clonal composition of breast tumors.
  • To investigate the genomic structural variations and heterogeneity within breast carcinomas.
  • To infer pathways of cancer progression and tumor growth organization.

Main Methods:

  • Sector-Ploidy-Profiling (SPP) was developed, involving tumor macro-dissection and flow-sorting of genomic subpopulations by DNA content.
  • Comparative genomic hybridization (CGH) was used to profile the genomes of sorted subpopulations.
  • Analysis focused on distinguishing monogenomic and polygenomic tumor classes.

Main Results:

  • Breast carcinomas were classified into monogenomic (single, stable clone) and polygenomic (multiple clones) types.
  • Polygenomic tumors exhibit heterogeneity arising from a few dominant clonal subpopulations, not gradual intermediates.
  • Comparison of subpopulations across different tumor locations elucidated progression pathways.

Conclusions:

  • Sector-Ploidy-Profiling (SPP) is an effective method for dissecting tumor clonal architecture.
  • Tumor heterogeneity in polygenomic breast cancers is driven by a limited number of key clonal expansions.
  • This study provides a framework for understanding cancer progression and tumor organization through clonal analysis.